Huang H, Chen B, Feng C, Chen W, Wu D
Virulence. 2025; 16(1):2473631.
PMID: 40033947
PMC: 11906112.
DOI: 10.1080/21505594.2025.2473631.
Tang J, Wang L, Zhou W, Mao Y, Zhang C, Shen J
CEN Case Rep. 2025; .
PMID: 40011366
DOI: 10.1007/s13730-025-00970-x.
Przybycinski J, Czerewaty M, Kwiatkowska E, Dziedziejko V, Safranow K, Domanski L
Genes (Basel). 2025; 16(2).
PMID: 40004454
PMC: 11854660.
DOI: 10.3390/genes16020125.
Gentile M, Goerlich N, Lo I, Olson N, McConnell M, Pospiech J
Kidney Int Rep. 2025; 10(2):475-488.
PMID: 39990906
PMC: 11843297.
DOI: 10.1016/j.ekir.2024.11.007.
Yao K, Zheng L, Chen W, Xie Y, Liao C, Zhou T
Front Immunol. 2025; 16:1438683.
PMID: 39981255
PMC: 11839611.
DOI: 10.3389/fimmu.2025.1438683.
The road ahead: emerging therapies for primary IgA nephropathy.
Filippone E, Gulati R, Farber J
Front Nephrol. 2025; 5:1545329.
PMID: 39968279
PMC: 11832374.
DOI: 10.3389/fneph.2025.1545329.
Efficacy and safety of telitacicept in IgA nephropathy: a real-world study.
Dong L, Yang D, Qin A, Wang S, Tang Y, Tan J
Ren Fail. 2025; 47(1):2449580.
PMID: 39780498
PMC: 11721934.
DOI: 10.1080/0886022X.2025.2449580.
Mucosal immune response in biology, disease prevention and treatment.
Zhou X, Wu Y, Zhu Z, Lu C, Zhang C, Zeng L
Signal Transduct Target Ther. 2025; 10(1):7.
PMID: 39774607
PMC: 11707400.
DOI: 10.1038/s41392-024-02043-4.
Establishment and validation of diagnostic model in immunoglobulin A nephropathy based on weighted gene co-expression network analysis.
Liu H, Dai L, Liu J, Duan K, Yi F, Li Z
Medicine (Baltimore). 2024; 103(48):e39930.
PMID: 39612439
PMC: 11608691.
DOI: 10.1097/MD.0000000000039930.
Post-transplant IgA nephropathy: a rapidly evolving field of kidney transplant medicine.
Kanbay M, Ozbek L, Guldan M, Copur S, Barratt J
J Nephrol. 2024; .
PMID: 39565563
DOI: 10.1007/s40620-024-02149-6.
The relationship between HBV antigens deposition in kidneys and renal prognosis in IgA nephropathy patients infected with HBV.
Guo Y, Li S, Wei J, Luo M, Liu H
Ren Fail. 2024; 46(2):2417737.
PMID: 39555693
PMC: 11574957.
DOI: 10.1080/0886022X.2024.2417737.
New Insights and Future Perspectives of APRIL in IgA Nephropathy.
Muto M, Suzuki H, Suzuki Y
Int J Mol Sci. 2024; 25(19).
PMID: 39408691
PMC: 11476402.
DOI: 10.3390/ijms251910340.
State-of-Art Therapeutics in IgA Nephropathy.
Mathur M, Sahay M, Pereira B, Rizk D
Indian J Nephrol. 2024; 34(5):417-430.
PMID: 39372635
PMC: 11450772.
DOI: 10.25259/ijn_319_23.
Identification of susceptibility loci and relevant cell type for IgA nephropathy in Han Chinese by integrative genome-wide analysis.
Li M, Hao X, Shi D, Cheng S, Zhong Z, Cai L
Front Med. 2024; 18(5):862-877.
PMID: 39343836
DOI: 10.1007/s11684-024-1086-2.
Causal association between peripheral immune cells and IgA nephropathy: a Mendelian randomization study.
Liang L, Xiong L, He X, Song L, Wang X, Lu Y
Front Immunol. 2024; 15:1371662.
PMID: 39221249
PMC: 11361932.
DOI: 10.3389/fimmu.2024.1371662.
Contemporary review of IgA nephropathy.
Filippone E, Gulati R, Farber J
Front Immunol. 2024; 15:1436923.
PMID: 39188719
PMC: 11345586.
DOI: 10.3389/fimmu.2024.1436923.
Characteristics and function of the gut microbiota in patients with IgA nephropathy via metagenomic sequencing technology.
Deng Y, Nong Z, Wei M, Xu Y, Luo Y, Li X
Ren Fail. 2024; 46(2):2393754.
PMID: 39177227
PMC: 11346320.
DOI: 10.1080/0886022X.2024.2393754.
Lactobacillus casei Cell Wall Extract and Production of Galactose-Deficient IgA1 in a Humanized IGHA1 Mouse Model.
Li R, Wang M, Li J, Zhu L, Xie X, Wang H
J Am Soc Nephrol. 2024; 36(1):60-72.
PMID: 39172518
PMC: 11706567.
DOI: 10.1681/ASN.0000000000000465.
The microbiota: a crucial mediator in gut homeostasis and colonization resistance.
Chen Y, Xiao L, Zhou M, Zhang H
Front Microbiol. 2024; 15:1417864.
PMID: 39165572
PMC: 11333231.
DOI: 10.3389/fmicb.2024.1417864.
Clinical implications of four different nutritional indexes in patients with IgA nephropathy.
Qian C, Li H, Hou Y, Wang W, Sun M
Front Nutr. 2024; 11:1431910.
PMID: 39149554
PMC: 11324556.
DOI: 10.3389/fnut.2024.1431910.